You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Pharma Ophthalmic Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

The global Pharma Ophthalmic market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Pharma Ophthalmic by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Retinal disorders drugs 
Allergic, inflammatory and infective drugs 
Glaucoma drugs 
Dry eye drugs 
Other ophthalmic drugs

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Novartis 
Allergan 
Roche 
Valeant 
Regeneron 
Santen 
Bayer 
Pfizer 
Senju 
Akorn

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Glaucoma 
Dry eye syndrome 
Retinal diseases 
Other ophthalmic indications

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
Table of Contents
1 Industry Overview
1.1 Pharma Ophthalmic Industry
Figure Pharma Ophthalmic Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Pharma Ophthalmic
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Pharma Ophthalmic
1.2.2 Downstream
Table Application Segment of Pharma Ophthalmic
Table Global Pharma Ophthalmic Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Pharma Ophthalmic Market by Type
3.1 By Type
3.1.1 Retinal disorders drugs 
Table Major Company List of Retinal disorders drugs 
3.1.2 Allergic, inflammatory and infective drugs 
Table Major Company List of Allergic, inflammatory and infective drugs 
3.1.3 Glaucoma drugs 
Table Major Company List of Glaucoma drugs 
3.1.4 Dry eye drugs 
Table Major Company List of Dry eye drugs 
3.1.5 Other ophthalmic drugs
Table Major Company List of Other ophthalmic drugs
3.2 Market Size
Table Global Pharma Ophthalmic Market 2016-2020, by Type, in USD Million
Figure Global Pharma Ophthalmic Market Growth 2016-2020, by Type, in USD Million
Table Global Pharma Ophthalmic Market 2016-2020, by Type, in Volume
Figure Global Pharma Ophthalmic Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Pharma Ophthalmic Market Forecast 2021-2026, by Type, in USD Million
Table Global Pharma Ophthalmic Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Novartis  (Company Profile, Sales Data etc.)
4.1.1 Novartis  Profile
Table Novartis  Overview List
4.1.2 Novartis  Products & Services
4.1.3 Novartis  Business Operation Conditions
Table Business Operation of Novartis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Allergan  (Company Profile, Sales Data etc.)
4.2.1 Allergan  Profile
Table Allergan  Overview List
4.2.2 Allergan  Products & Services
4.2.3 Allergan  Business Operation Conditions
Table Business Operation of Allergan  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Roche  (Company Profile, Sales Data etc.)
4.3.1 Roche  Profile
Table Roche  Overview List
4.3.2 Roche  Products & Services
4.3.3 Roche  Business Operation Conditions
Table Business Operation of Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Valeant  (Company Profile, Sales Data etc.)
4.4.1 Valeant  Profile
Table Valeant  Overview List
4.4.2 Valeant  Products & Services
4.4.3 Valeant  Business Operation Conditions
Table Business Operation of Valeant  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Regeneron  (Company Profile, Sales Data etc.)
4.5.1 Regeneron  Profile
Table Regeneron  Overview List
4.5.2 Regeneron  Products & Services
4.5.3 Regeneron  Business Operation Conditions
Table Business Operation of Regeneron  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Santen  (Company Profile, Sales Data etc.)
4.6.1 Santen  Profile
Table Santen  Overview List
4.6.2 Santen  Products & Services
4.6.3 Santen  Business Operation Conditions
Table Business Operation of Santen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Bayer  (Company Profile, Sales Data etc.)
4.7.1 Bayer  Profile
Table Bayer  Overview List
4.7.2 Bayer  Products & Services
4.7.3 Bayer  Business Operation Conditions
Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer  (Company Profile, Sales Data etc.)
4.8.1 Pfizer  Profile
Table Pfizer  Overview List
4.8.2 Pfizer  Products & Services
4.8.3 Pfizer  Business Operation Conditions
Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Senju  (Company Profile, Sales Data etc.)
4.9.1 Senju  Profile
Table Senju  Overview List
4.9.2 Senju  Products & Services
4.9.3 Senju  Business Operation Conditions
Table Business Operation of Senju  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Akorn (Company Profile, Sales Data etc.)
4.10.1 Akorn Profile
Table Akorn Overview List
4.10.2 Akorn Products & Services
4.10.3 Akorn Business Operation Conditions
Table Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Pharma Ophthalmic Sales Revenue 2016-2020, by Company, in USD Million
Table Global Pharma Ophthalmic Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Pharma Ophthalmic Sales Revenue Share in 2020, by Company, in USD Million
Table Global Pharma Ophthalmic Sales Volume 2016-2020, by Company, in Volume
Table Global Pharma Ophthalmic Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Pharma Ophthalmic Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Pharma Ophthalmic Market Concentration, in 2020
Figure Europe Pharma Ophthalmic Market Market Concentration, in 2020
Figure Asia-Pacific Pharma Ophthalmic MMarket Concentration, in 2020
Figure South America Pharma Ophthalmic Market Concentration, in 2020
Figure Middle East & Africa Pharma Ophthalmic Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Glaucoma 
Figure Pharma Ophthalmic Demand in Glaucoma , 2016-2020, in USD Million
Figure Pharma Ophthalmic Demand in Glaucoma , 2016-2020, in Volume
6.1.2 Demand in Dry eye syndrome 
Figure Pharma Ophthalmic Demand in Dry eye syndrome , 2016-2020, in USD Million
Figure Pharma Ophthalmic Demand in Dry eye syndrome , 2016-2020, in Volume
6.1.3 Demand in Retinal diseases 
Figure Pharma Ophthalmic Demand in Retinal diseases , 2016-2020, in USD Million
Figure Pharma Ophthalmic Demand in Retinal diseases , 2016-2020, in Volume
6.1.4 Demand in Other ophthalmic indications
Figure Pharma Ophthalmic Demand in Other ophthalmic indications, 2016-2020, in USD Million
Figure Pharma Ophthalmic Demand in Other ophthalmic indications, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Pharma Ophthalmic Demand Forecast 2021-2026, by Application, in USD Million
Figure Pharma Ophthalmic Market Growth 2021-2026, by Application, in USD Million
Figure Pharma Ophthalmic Market Share in 2026, by Application, in USD Million
Table Pharma Ophthalmic Demand Forecast 2021-2026, by Application, in Volume
Table Pharma Ophthalmic Market Growth 2021-2026, by Application, in Volume
Table Pharma Ophthalmic Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Pharma Ophthalmic Production 2016-2020, by Region, in USD Million
Table Pharma Ophthalmic Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Pharma Ophthalmic Market 2016-2020, by Region, in USD Million
Table Global Pharma Ophthalmic Market Share 2016-2020, by Region, in USD Million
Table Global Pharma Ophthalmic Market 2016-2020, by Region, in Volume
Table Global Pharma Ophthalmic Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure North America Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table North America Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure Europe Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table Europe Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure South America Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table South America Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Pharma Ophthalmic Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Pharma Ophthalmic Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Pharma Ophthalmic Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Pharma Ophthalmic Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Pharma Ophthalmic Market Forecast 2021-2026, by Region, in USD Million
Table Pharma Ophthalmic Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 87